◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Nxera Pharma Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 6.6B 5.0B 15.6B 17.7B 8.8B
Revenue Growth % 31.2% -67.8% -12.1% 100.3% --
+Operating Income -5.4B -9.5B 3.4B 3.8B 928.0M
Operating Margin % -82.4% -190.0% 22.1% 21.3% 10.5%
Non Operating Income 3.3B 132.0M 79.0M 621.0M 244.0M
Non Operating Expenses 256.0M 3.1B 570.0M 4.2B 1.2B
Ordinary Income -1.5B -3.3B -1.6B -4.7B -1.4B
Income Before Taxes -4.7B -10.7B 1.1B 433.0M 1.6B
Income Taxes 176.0M -3.5B 696.0M -584.0M 143.0M
+Net Income -4.8B -7.2B 382.0M 1.0B 1.5B
Net Margin % -73.5% -143.4% 2.5% 5.7% 16.7%
Eps 23.89 -39.81 -18.30 -52.47 -16.62
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Deposits 32.3B 49.1B 66.6B 60.1B 40.0B
Current Assets 57.9B 65.1B 69.9B 62.8B 42.0B
Property Plant Equipment 7.5B 7.9B 3.8B 3.8B 3.8B
Noncurrent Assets 93.6B 92.1B 29.5B 34.2B 34.4B
Total Assets 136.1B 142.0B 89.4B 94.3B 78.9B
Current Liabilities 8.2B 11.1B 1.0B 5.0B 621.0M
Total Liabilities 83.0B 90.4B 41.5B 39.5B 24.1B
Retained Earnings -20.9B -16.1B -8.9B -9.8B -10.8B
Total Equity 68.1B 65.2B 57.5B 58.5B 61.5B
Equity Ratio 0.50 0.46 0.64 0.62 0.77
Book Value Per Share 754.41 726.29 699.45 714.03 754.79
Num Employees 374.00 350.00 202.00 198.00 190.00
Roe 0.03 -- -- -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Operating Cash Flow -7.7B -5.3B 10.0B 7.1B 4.7B
Investing Cash Flow -4.8B -63.8B 1.0B 278.0M -150.0M
Financing Cash Flow -6.9B 48.3B -4.9B 11.1B 20.3B
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...